IFFIm appoints new board, $4 billion campaign to vaccinate poorest countries
The Switzerland-based GAVI Alliance (formerly the Global Alliance for Vaccines and Immunization) has appointed the newly-constituted board of the International Finance Facility of Immunization (IFFIm).
The IFFIm will provide $4.0 billion for vaccination over the next 10 years. This will enable the GAVI Alliance to reach the Millennium Development Goal for child health - reducing childhood mortality by two-thirds by 2015 - by investing in health systems and new vaccines.
The GAVI Alliance estimates that IFFIm funding will prevent the deaths of more than five million children from vaccine-preventable diseases within the next decade. The IFFIm's members are France, Italy, Norway Spain, Sweden and the UK.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze